Exelixis, Inc. (EXEL)
54.57
+0.49
(+0.91%)
USD |
NASDAQ |
Aug 24, 16:00
54.57
0.00 (0.00%)
After-Hours: 20:00
Exelixis Max Drawdown (5Y) : 53.09% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 53.09% |
| June 30, 2026 | 53.09% |
| May 31, 2026 | 53.09% |
| April 30, 2026 | 53.09% |
| March 31, 2026 | 53.09% |
| February 28, 2026 | 53.09% |
| January 31, 2026 | 53.09% |
| December 31, 2025 | 53.09% |
| November 30, 2025 | 53.09% |
| October 31, 2025 | 53.09% |
| September 30, 2025 | 53.09% |
| August 31, 2025 | 53.09% |
| July 31, 2025 | 53.09% |
| June 30, 2025 | 53.09% |
| May 31, 2025 | 53.09% |
| April 30, 2025 | 53.09% |
| March 31, 2025 | 53.09% |
| February 28, 2025 | 54.66% |
| January 31, 2025 | 54.66% |
| December 31, 2024 | 54.66% |
| November 30, 2024 | 54.66% |
| October 31, 2024 | 54.66% |
| September 30, 2024 | 54.66% |
| August 31, 2024 | 54.66% |
| July 31, 2024 | 54.66% |
| Date | Value |
|---|---|
| June 30, 2024 | 54.66% |
| May 31, 2024 | 54.66% |
| April 30, 2024 | 54.66% |
| March 31, 2024 | 54.66% |
| February 29, 2024 | 54.66% |
| January 31, 2024 | 54.66% |
| December 31, 2023 | 54.66% |
| November 30, 2023 | 54.66% |
| October 31, 2023 | 54.66% |
| September 30, 2023 | 57.20% |
| August 31, 2023 | 57.20% |
| July 31, 2023 | 57.20% |
| June 30, 2023 | 57.20% |
| May 31, 2023 | 57.20% |
| April 30, 2023 | 57.20% |
| March 31, 2023 | 57.20% |
| February 28, 2023 | 57.20% |
| January 31, 2023 | 57.20% |
| December 31, 2022 | 57.20% |
| November 30, 2022 | 57.20% |
| October 31, 2022 | 57.20% |
| September 30, 2022 | 57.20% |
| August 31, 2022 | 57.20% |
| July 31, 2022 | 57.20% |
| June 30, 2022 | 57.20% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Emergent BioSolutions, Inc. | 98.89% |
| Madrigal Pharmaceuticals, Inc. | 82.20% |
| United Therapeutics Corp. | 33.00% |
| AbbVie, Inc. | 21.89% |
| Tonix Pharmaceuticals Holding Corp. | 100.00% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 18.08 |
| Beta (5Y) | 0.4387 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 32.90% |
| Historical Sharpe Ratio (5Y) | 0.6723 |
| Historical Sortino (5Y) | 1.15 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 14.58% |